PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “Immunity, Humoral”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,441 records · Page 80Linked to original sources
PubMed1981

The immune system of cyprinid fish. Oxytetracycline and the regulation of humoral immunity in carp (Cyprinus carpio).

The antibiotic oxytetracycline (oxyTC) was administered either by mixing with food or by intraperitoneal injections. On oxyTC treated animals decreased serum immunoglobulin levels were found. The primary anti-sheep red blood cells (SRBC) response was measured by enumerating plaque forming cells (PFC). It was observed that the PFC response was depressed by 80-95% in oxyTC treated animals. When an anti-SRBC serum was injected together with SRBC the immunosuppressive effect of oxyTC was absent. A secondary anti-SRBC response was not inhibited by oxyTC. On base of the results a model for antigen presentation and the interaction between macrophages, T- and B-like cells during primary and secondary responses in fish is proposed. In primary responses cellular interaction is needed to develop a proper immune response whereas after a high antigen dose challenge SRBC might behave as a T-independent antigen.

Animals↗
PubMed1981

In vivo effects of antibodies to immune response gene products. I. Haplotype-specific suppression of humoral immune responses with a monoclonal anti-I-A.

Immune response (Ir) gene products control immunologic function at several critical sites. We administered in vivo a monoclonal antibody reactive with I-Ak to F1 mice with the genotype H-2k/b. These treated mnice made a markedly reduced antibody response to antigen (H,G)-A--L, under the control of I-Ak, but not to antigen (T,G)-A--L, under the control of I-Ab. This relative specificity was lost if the antigen was given in complete Freund's adjuvant rather than aqueous solution. The monoclonal antibody reduced the antibody titer in an ongoing, secondary response as well. Several potential mechanisms can be postulated for this effect. This haplotypic specificity might ultimately be relevant to human disease.

Animals↗
PubMed1988

Cell mediated and humoral immunity and light-chain proteinuria in rifampicin-treated tuberculous patients.

The present study was devoted to assess the humoral and cell mediated immune responsiveness in patients with pulmonary tuberculosis before and after rifampicin therapy. Skin test using PPD and PHA; Rosette forming cells test, serum IgG, M and A; and light chain proteinuria have been tested for 15 newly diagnosed tuberculous patients and 15 normal controls. Rifampicin showed an immunosuppressive effect on both cellular and humoral immune responses as well as by the advent of light chain proteinuria.

Humans↗
PubMed2001

The neutrophil: function and regulation in innate and humoral immunity.

The neutrophil is a critical effector cell in humoral and innate immunity and plays vital roles in phagocytosis and bacterial killing. Discussed here are the neutrophil components necessary for these processes and the diseases in which these components are either lacking or dysfunctional, illustrating that normal neutrophil function is vital for health.

Animals↗
PubMed1981

The utilization of native glioma antigens in the assessment of cellular and humoral immune responses in malignant glioma patients.

Cellular and humoral components of the immune response have been studied preoperatively, concurrently, and serially in patients with malignant glial neoplasms. In order to assess titres of circulating antibodies to tumour cell constituents an indirect immunofluorescent technique was applied to single cell suspensions and snap frozen cell smears. In an allogeneic system, 49% of 47 test and 7% of 124 control sera gave a positive response to cytoplasmic components. The leucocyte adherence inhibition assay was applied to study 39 test and 64 control patients. Significant non-adherence of leukocytes was observed in 77% of test cases. Control parameters indicated specificity of the response. Simultaneous assessment in 28 test patients yielded a positive response for one or both assays in 89% of cases..

Antibodies, Neoplasm↗
PubMed1988

Impairment of cellular but not humoral immune responses in chronic pulmonary and disseminated paracoccidioidomycosis in mice.

Humoral and cellular immune responses were measured during the progression of chronic pulmonary and disseminated paracoccidioidomycosis in mice. The chronic disease was established by pulmonary infection of mice with different doses of the yeast form of Paracoccidioides brasiliensis isolate GAP. Levels of antibodies to P. brasiliensis, detected in serum by immunodiffusion and enzyme-linked immunosorbent assay, directly correlated with the size of the infectious challenge. Significant delayed-type hypersensitivity (DTH) responses to antigen were largely restricted to week 1 after pulmonary infection with intranasally administered high doses (5.0 x 10(6) or 1.1 x 10(7) CFU per inoculum). In vitro lymphoproliferative responses of peripheral blood lymphocytes (PBL) to P. brasiliensis antigens were significant only at 2 weeks after infection with intranasally administered 1.1 x 10(7) CFU. Responses of PBL to concanavalin A were depressed (50% of control response) as early as 8 weeks and reached a nadir at 10 to 18 weeks after infection. Infected mice made antibodies to sheep erythrocytes (SRBC) (10(9) intravenously [i.v.]) normally at all times tested after infection. In contrast, infected mice sensitized to SRBC (10(6) i.v.) had significantly depressed DTH responses to SRBC at 9 and 20 weeks postinfection compared with noninfected mice. These results indicated that in this model, normal humoral responses developed to homologous and heterologous antigens. In contrast, the T cellular immune responses were depressed with progression and chronicity of the disease. Thus, this model closely mimics the immunological findings in human paracoccidioidomycosis.

Animals↗
PubMed1980

[Humoral immune response of cattle with anaplasmosis].

A study was carried out tracing the humoral and immune response of cows who have suffered from anaplasmosis (A. marginale). Selected antigens were utilized according to the method of McHardy and Gillson in a series of CF and RA serological tests. We studied 75 blood serums from 6 cows, taken periodically in the course of a year. The complement fixation antibodies reached their highest titre between the first and the second month after the infection (1:640) and their lowest titre towards the eleventh/twelfth month (1:40), whereas the agglutinative antibodies reached their highest titre between the second and the third month (1:64) and their lowest titre towards the twelfth month (1:4).

Agglutination Tests↗
PubMed1994

Comparison of humoral immunity and induction of proliferating T lymphocytes in vaccinia virus-infected rabbits and rhesus macaques.

Vaccina virus (VV) infection induces specific antibodies and cytotoxic T cells in various animal species. Therefore, helper T cells also should be induced that stimulate the humoral and cellular immune responses. We determined such helper T-cell activity in 2 species after VV infection. Rabbits and rhesus macaques were infected with the Copenhagen strain of VV or with recombinant VV expressing retroviral proteins. Animals of both species developed antibodies and specific proliferative T-cell response. This reactivity could be enhanced by booster infection with VV. The proliferating macaque cells were CD4+ and major histocompatibility complex class II-restricted. These data confirm the broad immunogenicity of VV. Expression of additional polypeptides expressed from a recombinant VV does not lead to altered immune response to VV antigens. However, strength of the helper T-cell response, as well as clinical reactions, differed between macaques and rabbits. Infection with recombinant VV as delivery vectors offers the opportunity for combined vaccination against recombinant proteins and does not diminish cellular and humoral immune responses to VV itself.

Animals↗
PubMed1982

Anaphylatoxin-mediated regulation of the immune response. I. C3a-mediated suppression of human and murine humoral immune responses.

The C3a fragment of the third component of complement was found to have immunosuppressive properties. C3a is capable of suppressing both specific and polyclonal antibody responses. In contrast, C3a had no effect on antigen- or mitogen-induced B or T cell proliferative responses. The carboxy-terminal arginine is essential for C3a to exhibit its immunosuppressive properties. The serum carboxypeptidase inhibitor 2-mercaptomethyl-5-guanodinopentanoic acid, which prevents cleavage of the terminal arginine that would produce C3ades Arg-77, allowed us to assay the effects of C3a on in vitro immune response systems where serum is required. When the terminal arginine is removed from C3a, the resulting C3ades Arg-77 molecule is nonsuppressive. Helper T lymphocytes are the target of C3a-mediated suppression of the immune response. Substitution of T cells by soluble T cell factors was found to abrogate the C3a suppressive activity.

Anaphylatoxins↗
PubMed2006

Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection.

To evaluate whether the rectal route of immunization may be used to provide appropriate protection against enteric pathogens such as rotaviruses (RV), we studied the antibody response and the protection induced by rectal immunization of mice with RV virus-like particles (VLP). For this purpose, 6-week-old BALBc mice were rectally immunized twice with RV 8-2/6/7-VLP derived from the bovine RV RF81 strain either alone or combined with various adjuvants including four toxins [cholera toxin (CT) and three attenuated Escherichia coli-derived heat-labile toxins (LTs), LT(R192G), LT(R72), and LT(K63)] and two Toll-like receptor-targeting adjuvants (CpG and resiquimod). Six weeks after the second immunization, mice were challenged with murine RV strain ECw. RV VLP administered alone were not immunogenic and did not protect mice against RV challenge. By contrast, RV VLP combined with any of the toxin adjuvants were immunogenic (mice developed significant titers of anti-RV immunoglobulin A [IgA] in both serum and feces and of anti-RV IgG in serum) and either efficiently induced complete protection of the mice (no detectable fecal virus shedding) or, for LT(K63), reduced the amount of fecal virus shedding after RV challenge. When combined with RV VLP, CpG and resiquimod failed to achieve protection, although CpG efficiently induced an antibody response to RV. These results support the consideration of the rectal route for the development of new immunization strategies against RV infection. Rectal delivery of a VLP-based vaccine might allow the use of adjuvants less toxic than, but as efficient as, CT.

Adjuvants, Immunologic↗
PubMed1980

Immune response to Mycobacterium leprae: further studies on the assessment of humoral immune response in mice.

Immuncyte proliferation in the spleens of mice given both a primary and a second infection sixty days later, was detected soon after the second challenge was administered. Plaque-forming cell assay for both the direct and developed plaques indicated that all cells producing antibody of both immunoglobulin classes were present in the animals when they were administered the second challenge. Hemagglutinating antibody determinations indicated that IgG antibodies are recognizable at a time when the bacilli reach a stage of maximum multiplication in the mouse host. The IgM antibodies, however, become detectable within a short time after infection in animals given either a single infection or a dual infection, one fifteen days later and the other sixty days after the first infection. It is proposed that the low level of circulating antibodies and antibody-producing cells despite continuous, as well as enhanced, antigenic challenge could be due to the fact that in the mouse footpad M. leprae may be intrinsically less antigenic than organisms that cause systemic infection. Quantitative immunoglobulin assays tended to confirm the observations on the HA studies. Present studies have once again confirmed our previous observations viz that the number of plaques in the spleens of mice infected with M. leprae increases on secondary stimulation, whether it is administered within a very short time after the primary infection or given later in the course of infection. They have also indicated that an IgG response will occur in the infected animals at a time when the bacillary multiplication enters the logarithmic phase of growth of M. leprae, They have, however, not permitted the placement of the mouse model in the overall spectrum of human leprosy.

Animals↗
PubMed1985

Cellular and humoral immune responses in sheep experimentally injected with killed and live Corynebacterium pseudotuberculosis.

Both humoral and cellular immune responses have been found to be operative in sheep experimentally injected with killed and live Corynebacterium pseudotuberculosis. However, immunity to sonicated C. pseudotuberculosis cells was primarily of humoral nature though cellular response was also noted. In contrast, live C. pseudotuberculosis cells evoked primarily a cellular response and the encountered humoral response was of lesser intensity. Challenge experiment revealed that humoral response alone was insufficient to protect, and the use of live cells to induce cellular response enhanced the immune status of sheep. It was also observed that nonvaccinated sheep in a herd can acquire immunity from their vaccinated counterparts suggesting a certain importance of 'herd immunity' in C. pseudotuberculosis vaccination.

Agglutinins↗
PubMed1988

Intact humoral immune response in patients on continuous ambulatory peritoneal dialysis.

After influenza vaccination no statistically significant difference in antibody response was observed between patients on continuous ambulatory peritoneal dialysis (CAPD) and healthy volunteers while a large group of hemodialysis (HD) patients was found to have a significantly lower response rate. This difference remained statistically significant when CAPD patients were compared to a matched HD group. As the antibody formation after influenza vaccination is a T cell-dependent phenomenon, the normal immune response to vaccination suggests an intact humoral and cellular immunity in CAPD patients.

Adolescent↗
PubMed1981

Cellular and humoral immune responses in calves experimentally infected with Salmonella dublin.

Both humoral and cellular immune responses have been found to be operative in calves surviving smooth Salmonella dublin infection. Such calves showed rises in agglutinin titre and serum immunoglobulin as compared to uninfected controls. These calves at 3 weeks post infection showed a 3-4 fold increase of initial skin thickness at 5 h post antigen inoculation - an indication of immediate type of skin hypersensitivity reaction. The maximum increase in skin thickness of 2-3 fold was observed at 48 h post antigen inoculation - a criterion of delayed type of hypersensitivity reaction. There was a moderate increase, 28.1 per cent in the migration inhibition of peripheral leucocytes during the first week and a sharp increase, 45.7 and 66.6 per cent during the second and third week post infection, respectively. Passively immunized calves on challenge exhibited delayed clinical symptoms and mortality as compared to control animals, though the calves could not be protected against challenge. The serum immunoglobulin levels in passively immunized calves decreased moderately during the first week and markedly during the second week post challenge while in the control calves the levels dropped abruptly in the first week followed by death in both groups.

Agglutinins↗
PubMed1990

Peripheral nerve allograft: cellular and humoral immune responses of mice.

Despite numerous experimental and clinical studies, no method has been established for achieving successful peripheral nerve allografts. One reason is that few studies concerning the immune response of the host have been conducted with nerve allografts. We therefore investigated the immune response of fresh nerve allografts with respect to both cellular and humoral immunological reactions. Using immunologically established strains of inbred mice, we performed the mixed lymphocyte culture (MLC) reaction and the cell-mediated lymphocytolysis reaction to test the cellular immune reaction and the complement-dependent cytotoxicity test to the humoral immune reaction. We observed that peripheral nerve tissues were strongly immunogenic; there was increased MLC reactivity to the allo-MHC antigen of the donor, specific cytotoxic T-cell activity, and production of specific antibody in the serum. For satisfactory nerve regeneration and transplantation, it is essential to suppress this immune response.

Animals↗
PubMed2002

Cellular and humoral immune responses to a human pancreatic cancer antigen, coactosin-like protein, originally defined by the SEREX method.

Among a number of human tumor antigens identified using the serological analysis of recombinant cDNA expression libraries (SEREX), only MAGE-1, tyrosinase, and NY-ESO-1 have been reported to be immunogenic tumor antigens that have the potential to elicit both humoral and cellular immunity. In this study, we determined whether our SEREX-defined pancreatic cancer antigens could be recognized by CTL, and report that one SEREX-defined antigen, coactosin-like protein (CLP), encoded cellular epitopes recognized by HLA-A2-restricted and tumor-reactive CTL. Three CLP peptides at positions 15-24, 57-65, and 10-113 possessed the ability to induce HLA-A2-restricted and tumor-reactive CTL from the PBMC of cancer patients. Subsequently, humoral responses to these peptides were investigated. IgG antibodies specific to the CLP 15-24, 57-65, and 104-113 peptides were detected in sera from 12, 0, and 12 of 12 cancer patients tested, and were also found in 5, 0, and 0 of 9 healthy donors, respectively. IgE antibodies specific to these peptides were also detected in sera from certain cancer patients and healthy donors. Since peptide-specific IgE was detected, type-I allergy to these peptides was tested. Unexpectedly the CLP 57-65 peptide, to which IgE was found in only 2 healthy donors, but not the other two peptides, was found to elicit an immediate-type hypersensitivity in all 10 healthy volunteers tested. These results indicate that identical antigenic peptides can be recognized by both cellular and humoral immune systems to a tumor-associated antigen. The CLP 15-24 and 104-113 peptides might be appropriate vaccine candidates for peptide-based immunotherapy of HLA-A2(+) cancer patients.

Adenocarcinoma↗